Lifecore Biomedical (LFCR) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free LFCR Stock Alerts $6.64 +0.31 (+4.90%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWhite Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surgeseekingalpha.com - April 20 at 2:13 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCRprnewswire.com - April 20 at 12:00 PMROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCprnewswire.com - April 19 at 11:15 PMLifecore Biomedical gets Nasdaq notice regarding delayed quarterly reportmsn.com - April 19 at 7:38 PMLifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Reportglobenewswire.com - April 19 at 4:30 PMLifecore Biomedical (LFCR) Price Target Decreased by 11.11% to 8.16msn.com - April 17 at 7:34 PMLFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCprnewswire.com - April 12 at 8:15 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCRprnewswire.com - April 12 at 9:30 AMROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDCbusinesswire.com - April 11 at 10:36 AMDo You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)?finance.yahoo.com - April 11 at 9:33 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCRprnewswire.com - April 4 at 7:10 PMLifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progressfinance.yahoo.com - April 1 at 9:11 AMGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investorsbusinesswire.com - March 28 at 3:00 PMINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investorsbusinesswire.com - March 28 at 12:47 PMLifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsbusinesswire.com - March 28 at 10:00 AMLifecore Biomedical, Inc.: Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Updatefinanznachrichten.de - March 28 at 4:39 AMThe Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investorsbusinesswire.com - March 26 at 8:31 PMLifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Updateglobenewswire.com - March 26 at 4:30 PMLifecore Class Action Lawsuit Investigation News - Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLPstockhouse.com - March 24 at 9:42 AMLifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLPbusinesswire.com - March 24 at 6:42 AMLifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsbusinesswire.com - March 21 at 5:54 PMKirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)businesswire.com - March 21 at 5:50 PMLifecore Shares Slide After Strategic Review Ends With No Dealmarketwatch.com - March 21 at 3:01 AMWhy Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionmsn.com - March 20 at 5:00 PMLifecore Biomedical, Inc.: Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023finanznachrichten.de - March 20 at 11:59 AMLifecore Biomedical: Board Concludes Review; To Execute Strategic Plan As Standalone Companymarkets.businessinsider.com - March 20 at 11:59 AMLifecore Biomedical concludes strategic evaluation process, names new CEOmsn.com - March 20 at 11:59 AMLifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changesglobenewswire.com - March 20 at 7:30 AMLifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023globenewswire.com - March 20 at 7:00 AMLFCR Apr 2024 7.500 callfinance.yahoo.com - March 16 at 6:27 PMLifecore Biomedical, Inc. (NASDAQ:LFCR) is Greenhaven Road Investment Management L.P.'s 6th Largest Positionmarketbeat.com - March 13 at 7:36 AMLFCR Mar 2024 10.000 callfinance.yahoo.com - February 17 at 3:55 AMLFCR Mar 2024 10.000 putfinance.yahoo.com - February 17 at 3:55 AMLifecore Biomedical receives Nasdaq notice of delistingmsn.com - February 16 at 5:18 PMLifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appealfinance.yahoo.com - February 16 at 5:18 PMLifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appealglobenewswire.com - February 16 at 4:05 PMLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by HAP Trading LLCmarketbeat.com - February 13 at 10:36 AMCove Street Capital LLC Sells 513,980 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR)marketbeat.com - February 12 at 4:37 PMStrength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?msn.com - February 6 at 11:19 AMShould You Hold Lifecore Biomedical (LFCR) for Long Term?finance.yahoo.com - January 30 at 9:04 AMLifecore Biomedical receives Nasdaq notice for delayed quarterly reportsmsn.com - January 12 at 7:04 PMEven after rising 12% this past week, Lifecore Biomedical (NASDAQ:LFCR) shareholders are still down 39% over the past five yearsfinance.yahoo.com - January 10 at 8:57 AMHere’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)finance.yahoo.com - January 8 at 6:51 AMLifecore Biomedical, Inc. (LFCR)ca.finance.yahoo.com - January 7 at 2:30 PMLifecore Biomedical, Inc.: Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangementsfinanznachrichten.de - January 5 at 3:49 PMLifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangementsfinance.yahoo.com - January 5 at 9:37 AMLifecore Biomedical, Inc. (LDE.F)finance.yahoo.com - December 25 at 7:16 PMLifecore Biomedical (LFCR) Set to Announce Earnings on Tuesdaymarketbeat.com - December 25 at 7:28 AMLifecore Biomedical, Inc.: Lifecore Biomedical Provides Business Updatefinanznachrichten.de - December 13 at 8:52 AMLifecore Biomedical Provides Business Updatefinance.yahoo.com - December 13 at 8:52 AM Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> LFCR Media Mentions By Week LFCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.060.41▲Average Medical News Sentiment LFCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼52▲LFCR Articles Average Week Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Omeros News Today Rigel Pharmaceuticals News Today Skye Bioscience News Today Organigram News Today Atossa Therapeutics News Today Vaccitech News Today NuCana News Today Zevra Therapeutics News Today Generation Bio News Today 23andMe News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
